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Eosinophilic gastroenteritis (EG) is a rare disease characterized by eosinophilic infiltration of portions of the gastrointestinal tract.
Eosinophilic ascites is probably the most unusual and rare presentation of EG and is generally associated with the serosal form
of EG. Hereby, we report a case of eosinophilic ascites with duodenal obstruction in a patient with liver cirrhosis. A 50-year-old
womanwas admitted to our hospital because of abdominal pain, nausea, bloating, and constipation. She had a history of laparotomy
because of duodenal obstruction 2 years ago. Based on clinical, radiological, endoscopic, and pathological findings, and given the
excluding the other causes of peripheral eosinophilia, the diagnosis of eosinophilic gastroenteritis along with liver cirrhosis and
spontaneous bacterial peritonitis was established. Based on the findings of the present case, it is highly recommended that, in the
patients presented with liver cirrhosis associated with peripheral blood or ascitic fluid eosinophilia, performing gastrointestinal
endoscopy and biopsy can probably reveal this rare disorder of EG.
1. Introduction
Eosinophilic gastroenteritis (EG) represents one member of
a family of diseases that includes eosinophilic esophagitis,
gastritis, enteritis, and colitis, collectively referred to as
eosinophilic gastrointestinal disorders [1]. Despite its rarity,
EG needs to be recognized by the clinician because this treat-
able disease can masquerade as irritable bowel syndrome.
The diagnosis of EG is confirmed by a characteristic biopsy
and/or eosinophilic ascitic fluid in the absence of infection by
intestinal parasites or other causes of intestinal eosinophilia.
The clinical features of EG are related to the layer(s)
and extent of bowel involved with eosinophilic infiltration:
mucosa, muscle, and/or subserosa [2].The prevalence of each
subtype is unknown because of reporting and referral biases.
Surgical series report a predominance of muscular disease
with obstruction [3], while medical series primarily describe
patients with mucosal involvement [4, 5]. The disease can
affect patients of any age, but typical presentations are in the
third through fifth decade with a male predominance [4, 6].
To the best of our knowledge, this is the first reported case
of eosinophilic ascites with duodenal obstruction in a patient
with liver cirrhosis from Iran.
2. Case Presentation
A 50-year-old woman was admitted to our hospital in August
2011 because of abdominal pain, abdominal distension, nau-
sea, bloating, and constipation. She had been experiencing
recurrent episodes of urticarial skin for 20 years before her
admission.There was no history of food allergies or bronchial
asthma.
She had a history of intermittent abdominal pain, bloat-
ing, and constipation 3 years ago. The patient underwent
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Figure 1: Abdominal CT scan showed a cirrhotic liver, spleno-
megaly, and ascites.
an exploratory laparotomy because of acute abdominal pain
and vomiting 2 years ago. During the operation, a large mass
was found in the third portion of the duodenum. The mass
was adherent to adjacent viscera. Also cirrhotic liver with
splenomegaly was seen.There was no lymphadenopathy.The
patient underwent a wedge biopsy of the cirrhotic liver and
unfortunately gastrojejunostomywithout removal and biopsy
of the mass was done. The histopathological examination of
the wedge biopsy of the liver revealed inactive cirrhosis. One
year after the operation, due to the persistence of abdominal
pain, bloating, and constipation, the patient was referred to
our hospital.
On physical examination, her height was 159 cm, weight
82 kg, and body mass index 32.43 kg/m2. The patient was
alert and showed no distress, was afebrile, and was hemo-
dynamically stable. The skin and mucosa were anicteric and
clear without spider angioma, and the cardiovascular and
thyroid examinations were normal. Physical findings of the
heart and lungs were normal. The abdomen was distended
and tender diffusely with shifting dullness present; no caput
medusae, rebound, or guarding was observed. Splenomegaly
and bilateral leg edema were present. No lymphadenopathy
was found.
Initial laboratory tests revealed a hemoglobin level of
10.5 g/dL (normal range, 12.0–16.0 g/dL), a hematocrit level
of 30.1% (normal, 37.0% to 47.0%), a mean corpuscular
volume of 79 fL (normal, 80.0–98.0 fL), a platelet count of
450,000/mm3 (normal, 150,000–450,000/mm3), and a white
blood cell of 18,700/mm3 (68% neutrophils, 5% lymphocytes,
and 27% eosinophils). Liver and renal functions were in nor-
mal range. Prick test results for food allergens were negative,
as was a stool examination for bacteria, ova, and parasites.
Tumor markers were normal. The serum immunoglobulin E
level was 1,900U/mL (normal, 6 to 90). The serum level of
erythrocyte sedimentation rate was 45mm/h, and those of
viral hepatitis serology, antinuclear antibody, and antineu-
trophil cytoplasmic antibody were normal. There was no
etiology for cirrhosis.
Analysis of the ascitic fluid revealed a white blood cell
of 3840 cu/mm (8% neutrophils, 10% lymphocytes, and 82%
eosinophils) (Figure 1), a glucose 110md/dL, a high pro-
tein content (4.15 g/dL), an elevated serum-ascites gradient
Figure 2: Ascitic fluid showing increased numerous eosinophils
(arrows) with Giemsa stain (original magnification ×600).
Figure 3: Colon biopsy shows colitis with marked eosinophilic
infiltration of the colonic mucosa (H&E stain, ×100).
(1.6 g/dL), and an adenosine deaminase 4 IU/L. There were
no malignant cells on cytological examination of the ascites.
In abdominal sonography, cirrhotic liver with splenomegaly,
ascites, and evidence of portal hypertension were seen, but
there was no tumoral mass. Abdominal computed tomogra-
phy (CT) revealed a cirrhotic liver, splenomegaly, and ascites
(Figure 2).
Upper gastrointestinal endoscopy was performed. Endo-
scopic examination revealed esophageal varices (grade Ι), evi-
dence of moderate pangastritis, and portal hypertensive gas-
tropathy (PHG). Location of gastrojejunostomywas visible in
the antrum. Mucosal biopsies were obtained. No eosinophils
in the mucosal biopsies were found. A total colonoscopy
showed erythematous patches in the cecum and transverse
colon, and target biopsies were performed. The final path-
ology report was compatible with colitis withmarked eosino-
philic infiltration of the colonic mucosa (Figure 3).
Based on CT, ascitic fluid analysis, colonoscopy, and
pathology report findings, and given the excluding the other
causes of peripheral eosinophilia, the diagnosis of eosino-
philic gastroenteritis along with liver cirrhosis and sponta-
neous bacterial peritonitis (SBP) was established.
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Figure 4: Abdominal CT scan showed complete absorption of asci-
tes one month after treatment.
We applied prednisone 40mg/day orally and cefotaxime
(2 gr intravenous every eight hours). With this treatment,
the patient’s symptoms regressed, and serum white blood
cell and eosinophil counts returned to normal levels after 7
days. Abdominal CT scan showed complete absorption of
ascites one month after treatment (Figure 4). The prednisone
dose was gradually tapered at follow-up as outpatient and
successfully stopped a year later. She has remained symptom-
free for more than 2 years posttreatment.
3. Discussion
Eosinophilic gastroenteritis (EG) is a rare, benign inflamma-
tory disorder of the gastrointestinal tract, characterised by
eosinophilic infiltration of the layers of the bowel wall, in the
absence of known causes of eosinophilia [4]. EG is classi-
fied histopathologically into 3 major types: (i) predominant
mucosal (60%), (ii) predominantmuscle layer (30%), and (iii)
predominant serosal (10%).
Eosinophilic mucosal infiltration produces nonspecific
symptoms which depend upon the organ(s) involved. The
entire gastrointestinal tract from esophagus to colon, includ-
ing bile ducts, can be affected [4, 7–9]. The previous sug-
gestion that EG has a predilection for the distal antrum and
proximal small bowel may have reflected a sampling bias
because of the availability of these areas for biopsy [2]. In a
retrospective study of 40 patients, the most common symp-
toms were abdominal pain, nausea, vomiting, and diarrhea,
suggesting a possible diagnosis of irritable bowel syndrome
[4]. Only one-third of patients had a weight loss of 2.4 kg or
more. Patients with diffuse small bowel disease can develop
malabsorption [2, 10]. The diagnosis of mucosal EG is
typically confirmed by endoscopic biopsies, which reveal ≥20
to 25 eosinophils per high power field onmicroscopic exami-
nation [4]. Upper endoscopy with biopsy of the stomach and
small intestine is diagnostic in at least 80 percent of patients
[11].
Eosinophilic infiltration of the muscle layer of the gas-
trointestinal tract results in a thickened, rigid gut and symp-
toms of intestinal obstruction such as nausea, vomiting, and
abdominal distention [2, 4, 10]. Pseudoachalasia, esophageal
stricture, perforation, or obstruction of the gastric outlet,
small bowel, or rarely the colon can occur depending on
the site of infiltration [2–4, 10]. Food intolerance or allergic
history is not usually present in patients with this form of
EG. Patients may present with a peripheral eosinophilia with
absolute eosinophil counts averaging 1000 cells/uL [4]. The
diagnosis of muscle layer disease is typically made after
resection of small bowel for obstruction. Endoscopic biopsies
should be performed, but they are often nondiagnostic
because mucosal involvement is lacking. In these cases,
laparoscopic full thickness biopsy is usually necessary to
exclude malignancy, thereby avoiding unnecessary radical
resectional surgery by confirming the diagnosis.
Patients with subserosal EG present with isolated ascites
or ascites in combination with symptoms characteristic of
mucosal or muscular EG [4]. The diagnostic feature is a
marked eosinophilia, up to 88 percent, in the ascitic fluid [2].
Patients in this subgroup may have an allergic history and
peripheral eosinophil counts as high as 8000 cells/uL [4]. An
eosinophilic pleural effusion may also be present [10].
The pathogenesis of EG is not well understood. Approx-
imately one-half of patients have allergic disease, such as
asthma, defined food sensitivities, eczema, or rhinitis [3, 4,
12]. Some patients have elevated serum IgE levels [2, 11]. In
allergic EG patients, but not those with conventional ana-
phylactic food allergy, a population of IL-5 expressing food
allergen specific T cells have been characterized.This suggests
that food exposure activates IL-5+T cells in EG, leading to gut
eosinophilia.
EG should be suspected in any patient with gastroin-
testinal symptoms associated with peripheral eosinophilia.
It should also be considered before making a diagnosis of
irritable bowel syndrome. As noted above, the diagnosis of
EG can bemade in almost all cases by suspicion in the appro-
priate clinical context and endoscopic or full thickness biopsy
or paracentesis. Data on the natural history and therapy of
EG are limited to case reports and retrospective series of less
than 20 patients. Untreated patients with EGmay rarely remit
spontaneously [13] or progress to severe malabsorption and
malnutrition [2]. The diagnosis of EG is based on the follow-
ing 3 criteria: (1) gastrointestinal symptoms, (2) eosinophilic
infiltration of 1 or more areas of the gastrointestinal tract, and
(3) exclusion of other causes of intestinal eosinophilia [10].
There have been no prospective, randomized therapeutic
clinical trials. Thus, treatment is empiric and based upon
the severity of the clinical manifestations. Patients who are
symptomatic or have evidence of malabsorption may be
treated with systemic glucocorticoids. Successful transition
from oral, conventional glucocorticoids to budesonide was
described in patients with EG involving the gastric antrum
and small intestine [14]. Oral cromolyn (800mg/day in four
divided doses) has been effective for short- and long-term
management in some [15], but not all [4], case reports.
Ketotifen (Zaditen), an H1-antihistamine, has been help-
ful in individual cases [16, 17]. The leukotriene antagonist,
montelukast, was effective in some reported cases [18] but not
in others [19]. In a preliminary report of four patients, treat-
mentwith a humanized anti-interleukin-5 antibodywas asso-
ciated with reduced peripheral and tissue eosinophil counts
but had no effect on symptoms [20]. Rebound eosinophilia
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has been observed after the drug was discontinued [21]. A
report of nine patients treated with omalizumab described
significant improvement in symptoms and measures of IgE
mediated allergy [6].
4. Conclusion
This case report reviews some of the characteristic clinical,
laboratory, and histopathological findings of a rare, readily
treatable, and easily missed disease. Based on the findings
of the present case, it is highly recommended that, in the
patients presentedwith liver cirrhosis associatedwith periph-
eral blood or ascitic fluid eosinophilia, performing gastroin-
testinal endoscopy and biopsy can probably reveal this rare
disorder of EG. Thus, awareness of this condition and timely
diagnosis and initiation of treatment would be of major
importance.
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